Hemagglutinin Nanoparticulate Vaccine with Controlled Photochemical Immunomodulation for Pathogenic Influenza‐Specific Immunity
Abstract Recently, viral infectious diseases, including COVID‐19 and Influenza, are the subjects of major concerns worldwide. One strategy for addressing these concerns focuses on nasal vaccines, which have great potential for achieving successful immunization via safe, easy, and affordable approach...
Main Authors: | Hayoon Jeong, Chung‐Sung Lee, Jangsu Lee, Jonghwan Lee, Hee Sook Hwang, Min Lee, Kun Na |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-12-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202100118 |
Similar Items
-
Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19
by: Jialu Huang, et al.
Published: (2022-03-01) -
A novel nanomicelle composed from PEGylated TB di-peptide could be successfully used as a BCG booster
by: Zohreh Firouzi, et al.
Published: (2022-02-01) -
A New Sampling Approach for the Detection of Swine Influenza a Virus on European Sow Farms
by: Kathrin Lillie-Jaschniski, et al.
Published: (2022-07-01) -
Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
by: Francisco Noé Fonseca, et al.
Published: (2023-08-01) -
Nasal commensal Staphylococcus epidermidis enhances interferon-λ-dependent immunity against influenza virus
by: Hyun Jik Kim, et al.
Published: (2019-05-01)